1 completed, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Falo, Louis, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC) Microneedle Array Doxorubicin (MNA-D) - Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | Falo, Louis, MD | 48 | 2023-09-13 | 2026-04-09 |
| Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) Micro needle array-Doxorubicin (MNA-D) - Cutaneous T Cell Lymphoma | Phase 1 | Completed | Falo, Louis, MD | 20 | 2016-03-09 | 2024-08-09 |
Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Doxorubicin (2) · Transdermal Patch (2)
United States (2)
P50CA254865 (1)